Nine new drugs recommended for approval by CHMP at May meeting

During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.

Photo: Peter Dejong/AP/Ritzau Scanpix

At its meeting in May, the European Medicines Agency’s (EMA) expert committee, the CHMP, has given its positive opinion for nine drugs, and has recommended that the indication be extended for four. Only two have not made the cut, according the committee’s meeting highlights.

A total of 38 drugs have now been recommended for approval by the Committee for Medicinal Products for Human Use in 2022.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs